{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T16:55:09Z","timestamp":1790787309765,"version":"4.1.0"},"reference-count":42,"publisher":"Impact Journals, LLC","issue":"24","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2016,6,14]]},"DOI":"10.18632\/oncotarget.8343","type":"journal-article","created":{"date-parts":[[2016,3,25]],"date-time":"2016-03-25T03:16:06Z","timestamp":1458875766000},"page":"35618-35631","source":"Crossref","is-referenced-by-count":60,"title":["Poly(ADP-ribose) polymerase 1 inhibition protects cardiomyocytes from inflammation and apoptosis in diabetic cardiomyopathy"],"prefix":"10.18632","volume":"7","author":[{"given":"Wei-dong","family":"Qin","sequence":"first","affiliation":[{"name":"Department of Critical Care Medicine, Qilu Hospital of Shandong University, Jinan, Shandong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guo-liang","family":"Liu","sequence":"additional","affiliation":[{"name":"The Henan Provincial Key Engineering Laboratory of Antibody Drugs, School of Medicine, Henan University, Kaifeng, Henan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Cardiology, The Second Hospital of Shandong University, Jinan, Shandong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Critical Care Medicine, Qilu Hospital of Shandong University, Jinan, Shandong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian-ning","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Critical Care Medicine, Qilu Hospital of Shandong University, Jinan, Shandong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fan","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Critical Care Medicine, Qilu Hospital of Shandong University, Jinan, Shandong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Ma","sequence":"additional","affiliation":[{"name":"Department of Critical Care Medicine, Qilu Hospital of Shandong University, Jinan, Shandong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin-ying","family":"Ji","sequence":"additional","affiliation":[{"name":"The Henan Provincial Key Engineering Laboratory of Antibody Drugs, School of Medicine, Henan University, Kaifeng, Henan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Critical Care Medicine, Qilu Hospital of Shandong University, Jinan, Shandong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming-xiang","family":"Zhang","sequence":"additional","affiliation":[{"name":"The Key Laboratory of Cardiovascular Remodeling and Function Research, Chinese Ministry of Education and Chinese Ministry of Public Health, Qilu Hospital of Shandong University, Jinan, Shandong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7892","published-online":{"date-parts":[[2016,3,24]]},"reference":[{"key":"1","doi-asserted-by":"crossref","first-page":"3059","DOI":"10.1073\/pnas.96.6.3059","article-title":"Poly(adp-ribose) polymerase-deficient mice are protected from streptozotocin-induced diabetes","volume":"96","author":"Snyder","year":"1999","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2","doi-asserted-by":"crossref","first-page":"2963","DOI":"10.2337\/db11-0549","article-title":"Trb3 gene silencing alleviates diabetic cardiomyopathy in a type 2 diabetic rat model","volume":"60","author":"Zhang","year":"2011","journal-title":"Diabetes"},{"key":"3","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1161\/01.HYP.0000153316.59262.79","article-title":"Role of rho-kinase and p27 in angiotensin ii-induced vascular injury","volume":"45","author":"Saruta","year":"2005","journal-title":"Hypertension"},{"key":"4","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.neo.2015.03.001","article-title":"Igf-1r inhibition activates a yes\/sfk bypass resistance pathway: Rational basis for co-targeting igf-1r and yes\/sfk kinase in rhabdomyosarcoma","volume":"17","author":"Helman","year":"2015","journal-title":"Neoplasia"},{"key":"5","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.2337\/db06-1662","article-title":"Cardioprotective and anti-inflammatory effects of interleukin converting enzyme inhibition in experimental diabetic cardiomyopathy","volume":"56","author":"Tsch\u00f6pe","year":"2007","journal-title":"Diabetes"},{"key":"6","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.toxlet.2009.03.001","article-title":"Taurine protects rat testes against naaso(2)-induced oxidative stress and apoptosismitochondrial dependent and independent pathways","volume":"187","author":"Sil","year":"2009","journal-title":"Toxicol Lett"},{"key":"7","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.2337\/diabetes.51.6.1938","article-title":"Hyperglycemia-induced apoptosis in mouse myocardium: Mitochondrial cytochrome c-mediated caspase-3 activation pathway","volume":"51","author":"Kang","year":"2002","journal-title":"Diabetes"},{"key":"8","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.2337\/db08-1697","article-title":"Inactivation of gsk-3beta by metallothionein prevents diabetes-related changes in cardiac energy metabolism, inflammation, nitrosative damage, and remodeling","volume":"58","author":"Cai","year":"2009","journal-title":"Diabetes"},{"key":"9","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1016\/j.jacc.2006.07.022","article-title":"Attenuation by metallothionein of early cardiac cell deathsuppression of mitochondrial oxidative stress results in a prevention of diabetic cardiomyopathy","volume":"48","author":"Kang","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"10","doi-asserted-by":"crossref","first-page":"19725","DOI":"10.1073\/pnas.1108586108","article-title":"The inflammasome promotes adverse cardiac remodeling following acute myocardial infarction in the mouse","volume":"108","author":"Abbate","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"11","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s11010-008-9754-0","article-title":"Lipopolysaccharide induces cellular hypertrophy through calcineurin\/nfat-3 signaling pathway in h9c2 myocardiac cells","volume":"313","author":"Huang","year":"2008","journal-title":"Mol Cell Biochem"},{"key":"12","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1161\/CIRCULATIONAHA.106.643585","article-title":"Tumor necrosis factor-alpha mediates cardiac remodeling and ventricular dysfunction after pressure overload state","volume":"115","author":"Liu","year":"2007","journal-title":"Circulation"},{"key":"13","doi-asserted-by":"crossref","first-page":"2692","DOI":"10.1172\/JCI29134","article-title":"Tnf provokes cardiomyocyte apoptosis and cardiac remodeling through activation of multiple cell death pathways","volume":"117","author":"Mann","year":"2007","journal-title":"J Clin Invest"},{"key":"14","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.2337\/diabetes.50.6.1414","article-title":"Igf-1 overexpression inhibits the development of diabetic cardiomyopathy and angiotensin ii-mediated oxidative stress","volume":"50","author":"Anversa","year":"2001","journal-title":"Diabetes"},{"key":"15","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1093\/cvr\/cvq373","article-title":"Peroxynitrite induces hmgb1 release by cardiac cellsand hmgb1 upregulation in the infarcted myocardium","volume":"89","author":"Liaudet","year":"2011","journal-title":"Cardiovasc Res"},{"key":"16","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1210\/er.2003-0012","article-title":"Diabetic cardiomyopathy: Evidence, mechanisms, and therapeutic implications","volume":"25","author":"Marwick","year":"2004","journal-title":"Endocr Rev"},{"key":"17","doi-asserted-by":"crossref","first-page":"2","DOI":"10.2353\/ajpath.2008.080019","article-title":"Role of the peroxynitrite-poly(adp-ribose)polymerase pathway in human disease","volume":"173","author":"Szabo","year":"2008","journal-title":"The American Journal of Pathology"},{"key":"18","doi-asserted-by":"crossref","first-page":"3046","DOI":"10.2741\/2909","article-title":"The diverse biological roles of mammalian parps, a small but powerful family of poly-adp-ribose polymerases","volume":"13","author":"Hottiger","year":"2008","journal-title":"Front Biosci"},{"key":"19","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1073\/pnas.93.5.1753","article-title":"DNA strand breakage, activation of poly (adp-ribose) synthetase, and cellular energy depletion are involved in the cytotoxicity of macrophages and smooth muscle cells exposed to peroxynitrite","volume":"93","author":"Salzman","year":"1996","journal-title":"Proc Natl Acad Sci U S A"},{"key":"20","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1007\/s00018-002-8527-2","article-title":"The functional role of poly(adp-ribose)polymerase 1 as novel coactivator of nf-kappab in inflammatory disorders","volume":"59","author":"Hottiger","year":"2002","journal-title":"Cell Mol Life Sci"},{"key":"21","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1161\/01.RES.83.1.85","article-title":"Genetic disruption of poly (adp-ribose) synthetase inhibits the expression of p-selectin and intercellular adhesion molecule-1 in myocardial ischemia\/reperfusion injury","volume":"83","author":"Szabo","year":"1998","journal-title":"Circ Res"},{"key":"22","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1038\/nm1097-1089","article-title":"Poly(adp-ribose) polymerase gene disruption renders mice resistant to cerebral ischemia","volume":"3","author":"Dawson","year":"1997","journal-title":"Nat Med"},{"key":"23","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1172\/JCI119585","article-title":"Endothelial dysfunction in a rat model of endotoxic shock. Importance of the activation of poly (adp-ribose) synthetase by peroxynitrite","volume":"100","author":"Salzman","year":"1997","journal-title":"J Clin Invest"},{"key":"24","doi-asserted-by":"crossref","first-page":"35767","DOI":"10.1074\/jbc.M507075200","article-title":"Pivotal role of akt activation in mitochondrial protection and cell survival by poly(adp-ribose)polymerase-1 inhibition in oxidative stress","volume":"280","author":"Sumegi","year":"2005","journal-title":"J Biol Chem"},{"key":"25","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/2044-5040-1-4","article-title":"Regulation of skeletal muscle growth by the igf1-akt\/pkb pathway: Insights from genetic models","volume":"1","author":"Mammucari","year":"2011","journal-title":"Skelet Muscle"},{"key":"26","doi-asserted-by":"crossref","first-page":"711","DOI":"10.2337\/diabetes.53.3.711","article-title":"Role of poly(adp-ribose) polymerase activation in diabetic neuropathy","volume":"53","author":"Stevens","year":"2004","journal-title":"Diabetes"},{"key":"27","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.2337\/db09-1456","article-title":"Cardiac-specific igf-1 receptor transgenic expression protects against cardiac fibrosis and diastolic dysfunction in a mouse model of diabetic cardiomyopathy","volume":"59","author":"Ritchie","year":"2010","journal-title":"Diabetes"},{"key":"28","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1161\/01.RES.87.12.1123","article-title":"Myocardial cell death in human diabetes","volume":"87","author":"Anversa","year":"2000","journal-title":"Circ Res"},{"key":"29","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1152\/physrev.00029.2006","article-title":"Nitric oxide and peroxynitrite in health and disease","volume":"87","author":"Liaudet","year":"2007","journal-title":"Physiol Rev"},{"key":"30","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/83241","article-title":"Diabetic endothelial dysfunction: the role of poly(ADP-ribose) polymerase activation","volume":"7","author":"Szab\u00f3","year":"2001","journal-title":"Nat Med"},{"key":"31","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1172\/JCI18127","article-title":"Inhibition of GAPDH activity by poly(ADP-ribose) polymerase activates three major pathways of hyperglycemic damage in endothelial cells","volume":"112","author":"Brownlee","year":"2003","journal-title":"J Clin Invest"},{"key":"32","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1111\/j.1538-7836.2004.00835.x","article-title":"Intermittent high glucose enhances ICAM-1, VCAM-1, E-selectin and interleukin-6 expression in human umbilical endothelial cells in culture: the role of poly(ADP-ribose) polymerase","volume":"2","author":"Ceriello","year":"2004","journal-title":"J Thromb Haemost"},{"key":"33","doi-asserted-by":"crossref","first-page":"514","DOI":"10.2337\/diabetes.51.2.514","article-title":"The role of poly(ADP-ribose) polymerase activation in the development of myocardial and endothelial dysfunction in diabetes","volume":"51","author":"Szab\u00f3","year":"2002","journal-title":"Diabetes"},{"key":"34","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1038\/nrd1718","article-title":"Poly(adp-ribose) polymerase and the therapeutic effects of its inhibitors","volume":"4","author":"Szabo","year":"2005","journal-title":"Nat Rev Drug Discov"},{"key":"35","doi-asserted-by":"crossref","first-page":"2585","DOI":"10.1006\/jmcc.1997.0496","article-title":"Protection by inhibition of poly(ADP-ribose) synthetase against oxidant injury in cardiac myoblasts","volume":"29","author":"Szab\u00f3","year":"1997","journal-title":"J Mol Cell Cardiol"},{"key":"36","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0014-2999(01)01359-0","article-title":"5-aminoisoquinolinone, a potent inhibitor of poly(adenosine 5\u2032-diphosphate ribose) polymerase, reduces myocardial infarct size","volume":"430","author":"Thiemermann","year":"2001","journal-title":"Eur J Pharmacol"},{"key":"37","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.yjmcc.2008.06.009","article-title":"PARP mediates structural alteration in diabetic cardiomyopathy","volume":"45","author":"Chakrabarti","year":"2008","journal-title":"J Mol Cell Cardiol"},{"key":"38","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1172\/JCI119730","article-title":"Overexpression of insulin-like growth factor-1 in mice protects from myocyte death after infarction, attenuating ventricular dilation, wall stress, and cardiac hypertrophy","volume":"100","author":"Anversa","year":"1997","journal-title":"J Clin Invest"},{"key":"39","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1161\/01.RES.84.9.1007","article-title":"Insulin-like growth factor-1 attenuates the detrimental impact of nonocclusive coronary artery constriction on the heart","volume":"84","author":"Anversa","year":"1999","journal-title":"Circ Res"},{"key":"40","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1210\/er.2006-0001","article-title":"The role of the igf system in cancer growth and metastasis: Overview and recent insights","volume":"28","author":"Brodt","year":"2007","journal-title":"Endocr Rev"},{"key":"41","doi-asserted-by":"crossref","first-page":"2503","DOI":"10.1002\/j.1460-2075.1986.tb04528.x","article-title":"Insulin-like growth factor i receptor primary structure: Comparison with insulin receptor suggests structural determinants that define functional specificity","volume":"5","author":"Chen","year":"1986","journal-title":"EMBO J"},{"key":"42","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1007\/PL00000744","article-title":"Structure and function of the type 1 insulin-like growth factor receptor","volume":"57","author":"Ward","year":"2000","journal-title":"Cell Mol Life Sci"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.8343","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,11]],"date-time":"2020-05-11T20:34:42Z","timestamp":1589229282000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.8343"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3,24]]},"references-count":42,"journal-issue":{"issue":"24","published-print":{"date-parts":[[2016,6,14]]}},"alternative-id":["8343","27027354"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.8343","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,3,24]]}}}